Skip to the main content

Meeting abstract

https://doi.org/10.15836/ccar2024.127

Atrial fibrillation and electrocardioversion: a single-center retrospective analysis

Josip Silović orcid id orcid.org/0009-0002-9918-7575 ; General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia
Josip Ereiz ; General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia
Ana Kovačević orcid id orcid.org/0000-0002-8909-9216 ; General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia
Katica Cvitkušić Lukenda orcid id orcid.org/0000-0001-6188-0708 ; General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia


Full text: english pdf 394 Kb

page 127-128

downloads: 173

cite

Download JATS file


Abstract

Keywords

atrial fibrillation; cardioversion; recurrence

Hrčak ID:

314344

URI

https://hrcak.srce.hr/314344

Publication date:

8.2.2024.

Visits: 570 *



Introduction: Atrial fibrillation (AF) is one of the most common arrhythmia in clinical practice. Apart from pharmaceutical, one of the most successful methods for achieving sinus rhythm is electrocardioversion (ECV). Although we can quickly achieve sinus rhythm with ECV, maintaining it is a challenge. Data from the literature suggest that there are certain predictors associated with the recurrence of AF, such as the duration of AF and long-standing arterial hypertension (1). Recurrence usually does not occur within 24 hours of cardioversion (2). An early catheter ablation strategy may potentially reduce the recurrence of AF (3,4). We made a retrospective analysis of patients who underwent successful ECV through the emergency hospital admission and the Cardiology Day Hospital at the General Hospital “Dr. Josip Benčević“. Aim: To determine the relationship between gender, left ventricular ejection fraction, use of antiarrhythmic drugs, and comorbidities with recurrence of AF after successful ECV.

Patients and Methods: We used data from the hospital information system according to the ECV procedure performed from January 1, 2021 to December 31, 2022. Age, gender, use of antiarrhythmic (amiodarone/dronedarone), left ventricular ejection fraction, and recurrence of AF were analyzed. Categorical variables were analyzed with Fisher’s exact test, while numerical variables underwent Student’s t-test with Mann Whitney U test for correlation. P<0.05 was considered statistically significant.

Results: In the study, 91 patients participated, including 64 (70.3%) males and 27 (29.7%) females. The median age was 66 years with an interquartile range of 58 to 73 years. Out of the total, 39 (42.9%) patients experienced a recurrence, while 52 (57.1%) did not. There was no correlation between patient age and recurrence (median age at recurrence 66, IQR 60-74 vs without recurrence 67.5, IQR 58-73; p=0.6, Mann Whitney U test). We did not find statistically significant differences according to gender, left ventricular ejection fraction, use of antiarrhythmics, and comorbidities (Figure 1, 2, 3{ label needed for fig[@id='f2'] }{ label needed for fig[@id='f3'] }, and Table 1).

FIGURE 1 The recurrence depending on gender. No statistically significant difference was observed (p>0.9, Fisher’s Exact Test).
CC202419_3-4_127-8-f1
{ label needed for fig[@id='f2'] }
FIGURE 2 Recurrence based on left ventricular ejection fraction (LVEF). No statistically significant difference was detected (p=0.8, Fisher’s Exact Test).
CC202419_3-4_127-8-f2
{ label needed for fig[@id='f3'] }
FIGURE 3 Illustration of recurrence based on the use of antiarrhythmics following electrical cardioversion. No statistically significant difference was detected (p=0.5, Fisher’s Exact Test).
CC202419_3-4_127-8-f3
TABLE 1 Display of recurrence depending on comorbidities.
Number (%)
YesNoTotalp*
Comorbidities
Arterial hypertension29 (74.4)39 (75)68 (74.7)>0.9
Chronic kidney disease5 (12.8)3 (5.8)8 (8.8)0.3
Dyslipidemia21 (53.8)30(57.7)51 (56)0.8
Coronary artery disease7 (17.9)8 (15.4)15 (16.5)0.8
Type 2 diabetes mellitus6 (15.4)7 (13.5)13 (14.3)>0.9
* Fisher’s Exact Test

Conclusion: Although ECV is a successful method for achieving sinus rhythm, it does not predict or affect its maintenance. Therefore, it is necessary to consider a catheter ablation strategy as early as possible.

LITERATURE

1 

Karaliūtė R, Leleika A, Apanavičiūtė I, Kazakevičius T, Mizarienė V, Zabiela V, et al. Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved. Medicina (Kaunas). 2022 August 4;58(8):1053. https://doi.org/10.3390/medicina58081053 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/36013520

2 

Weijs B, Limantoro I, Delhaas T, de Vos CB, Blaauw Y, Houben RPM, et al. Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring. Clin Cardiol. 2018 March;41(3):366–71. https://doi.org/10.1002/clc.22877 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/29569353

3 

Cvitkušić Lukenda K, Bitunjac I, Jakab J, Miškić B, Velagić V. Efficacy and safety of cryoisolation of pulmonary veins – a single-center retrospective analysis. Cardiol Croat. 2022;17(9-10):173. https://doi.org/10.15836/ccar2022.173

4 

Charitakis E, Dragioti E, Stratinaki M, Korela D, Tzeis S, Almroth H, et al. Predictors of recurrence after catheter ablation and electrical cardioversion of atrial fibrillation: an umbrella review of meta-analyses. Europace. 2023 February 8;25(1):40–8. https://doi.org/10.1093/europace/euac143 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/36037026


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.